ArticleOncotarget2016

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

Shalaka S Hampras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.